Effects of Intravitreal Injection Bevacizumab in Posterior Segment Vasculopathies - A Clinical Study
Abstract: Aim: The aimwas to study effects of intravitreal anti - vascular endothelial growth factor injection Avastin in posterior segment vasculopathies. Methods: In this prospective, single centre study, 79 eyes, including bilateral cases in age group 61 - 70 years of different posterior segment vasculopathies were given bevacizumab with dose of 1.25mg/0.05ml. post - operative vision was assessed, and OCT was done immediately and on follow up after 1 week, 4weeks. Results: Out of 79 eyes with age group 61 - 70 years, 58.67% of subjects were male and 34.67% of them were females respectively, majority were with PDR (28%) followed by BRVO (26%), CNVM (24%), CRVO (12%), ROP (6.67%), NG (1.33%) and wetARMD (1.33%) out of which there were 9 bilateral cases, 5 cases belong to PDR and intravitreal injection bilaterally was required while there were 4 bilateral active CNVM cases. majority of subjects had hypertension (41.42%) and diabetes mellitus (41.42%). Out of 5 babies 1 baby had respiratory distress. Majority of subjects had IOP 10 - 21 mm of Hg in right eye (97.14%) and left eye (92.86%) and majority of subjects had visual acuity
Keywords: Retinopathy, vasculopathy, bevacizumab, vascular endothelial growth factor
How to Cite?: Dr. Abhiraj Mane, Dr. V. H. Karambelkar, Dr. Girish Gadre, Dr. Sanvedya Kadam, "Effects of Intravitreal Injection Bevacizumab in Posterior Segment Vasculopathies - A Clinical Study", Volume 12 Issue 9, September 2023, International Journal of Science and Research (IJSR), Pages: 752-756, https://www.ijsr.net/getabstract.php?paperid=SR23905161226, DOI: https://dx.doi.org/10.21275/SR23905161226